Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment

Author： Moton Allen   Krishna Gopal   Ma Lei   O’Mara Edward   Prasad Pratapa   McLeod James   Preston Richard A.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.1, 2010-01, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of hepatic impairment on lenvatinib pharmacokinetics following single‐dose oral administration

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 3, 2015-03 ,pp. : 317-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 357-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of serelaxin in patients with hepatic impairment: a single‐dose, open‐label, parallel group study

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 6, 2015-06 ,pp. : 937-945

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of oral posaconazole on the pharmacokinetics of sirolimus

By Moton Allen   Ma Lei   Krishna Gopal   Martinho Monika   Seiberling Michael   McLeod James  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 701-707

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 525-533

John Wiley & Sons Inc

Access to resources Recommend Favorite